JP2002539089A - 成長ホルモン分泌促進薬 - Google Patents

成長ホルモン分泌促進薬

Info

Publication number
JP2002539089A
JP2002539089A JP2000599774A JP2000599774A JP2002539089A JP 2002539089 A JP2002539089 A JP 2002539089A JP 2000599774 A JP2000599774 A JP 2000599774A JP 2000599774 A JP2000599774 A JP 2000599774A JP 2002539089 A JP2002539089 A JP 2002539089A
Authority
JP
Japan
Prior art keywords
mmol
product
preparation
give
embedded image
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000599774A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002539089A5 (https=
Inventor
ジェフリー・アラン・ドッジ
チャールズ・ウィリス・ラガー・ザ・サード
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of JP2002539089A publication Critical patent/JP2002539089A/ja
Publication of JP2002539089A5 publication Critical patent/JP2002539089A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
JP2000599774A 1999-02-19 2000-02-18 成長ホルモン分泌促進薬 Pending JP2002539089A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12081399P 1999-02-19 1999-02-19
US60/120,813 1999-02-19
PCT/US2000/004274 WO2000049037A1 (en) 1999-02-19 2000-02-18 Growth hormone secretagogues

Publications (2)

Publication Number Publication Date
JP2002539089A true JP2002539089A (ja) 2002-11-19
JP2002539089A5 JP2002539089A5 (https=) 2007-07-05

Family

ID=22392709

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000599774A Pending JP2002539089A (ja) 1999-02-19 2000-02-18 成長ホルモン分泌促進薬

Country Status (13)

Country Link
EP (1) EP1153034B1 (https=)
JP (1) JP2002539089A (https=)
CN (1) CN1179972C (https=)
AR (1) AR023369A1 (https=)
AT (1) ATE375996T1 (https=)
AU (1) AU765642B2 (https=)
BR (1) BR0008321A (https=)
CA (1) CA2362303A1 (https=)
CO (1) CO5160260A1 (https=)
DE (1) DE60036785D1 (https=)
IL (1) IL144350A0 (https=)
PE (1) PE20001468A1 (https=)
WO (1) WO2000049037A1 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6639076B1 (en) 1998-08-18 2003-10-28 Eli Lilly And Company Growth hormone secretagogues
US6828331B1 (en) 1999-02-19 2004-12-07 Eli Lilly And Company Growth hormone secretagogues
JP2003534377A (ja) 2000-05-30 2003-11-18 メルク エンド カムパニー インコーポレーテッド メラノコルチン受容体作働薬
US6756385B2 (en) * 2000-07-31 2004-06-29 Pfizer Inc. Imidazole derivatives
GT200100147A (es) * 2000-07-31 2002-06-25 Derivados de imidazol
US20040106665A1 (en) * 2000-10-13 2004-06-03 Kress Thomas Joseph Resolution process for preparation of substantially pure (r) and (s) enantiomers of 2-(4-nitroimidazolyl)-4-methodxyphenylpropionic acid and salts thereof
US7560490B2 (en) * 2001-01-23 2009-07-14 Gador S.A. Composition comprising bisphosphonates for prevention and/or treatment of metabolic diseases of bones, process for preparing such composition and use thereof
US7125840B2 (en) 2001-10-09 2006-10-24 Eli Lilly And Company Substituted dipeptides as growth hormone secretagogues
US7396846B2 (en) 2002-04-09 2008-07-08 Eli Lilly And Company Growth hormone secretagogues
DK1730119T3 (da) * 2004-03-23 2008-08-11 Pfizer Prod Inc Imidazolforbindelser til behandling af neurodegenerative forstyrrelser
AU2006293619A1 (en) 2005-09-22 2007-03-29 Pfizer Products Inc. Imidazole compounds for the treatment of neurological disorders
PL4010322T3 (pl) 2019-08-09 2026-02-16 Pfizer Inc. Stałe postacie (s)-2-(((s)-6,8-difluoro-1,2,3,4-tetrahydronaftalen-2-ylo)amino)-n-(1-(2-metylo-1-(neopentyloamino)propan-2-ylo)-1h-imidazol-4-ilo)pentanamidu i ich zastosowanie
US11884634B2 (en) 2019-08-09 2024-01-30 Pfizer Inc. Compositions of solid forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4- tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide
AU2022339841A1 (en) 2021-09-01 2024-03-28 Springworks Therapeutics, Inc. Synthesis of nirogacestat
US11504354B1 (en) 2021-09-08 2022-11-22 SpringWorks Therapeutics Inc.. Chlorinated tetralin compounds and pharmaceutical compositions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL107836A (en) * 1992-12-11 1998-01-04 Merck & Co Inc Spiro piperidines and homologues, their preparation and pharmaceutical preparations containing them
WO1994013696A1 (en) * 1992-12-11 1994-06-23 Merck & Co., Inc. Spiro piperidines and homologs which promote release of growth hormone
US5721250A (en) * 1993-12-23 1998-02-24 Merck & Co. Inc. Di-and tri-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone
WO1998016527A1 (en) * 1996-10-15 1998-04-23 Fujisawa Pharmaceutical Co., Ltd. Benzoxepine derivatives which promote release of growth hormone
ZA987383B (en) * 1997-08-19 2000-02-17 Lilly Co Eli Treatment of congestive heart failure with growth hormone secretagogues.
ZA987385B (en) * 1997-08-19 2000-04-18 Lilly Co Eli Growth hormone secretagogues.

Also Published As

Publication number Publication date
WO2000049037A1 (en) 2000-08-24
CO5160260A1 (es) 2002-05-30
AU3496800A (en) 2000-09-04
AU765642B2 (en) 2003-09-25
EP1153034B1 (en) 2007-10-17
AR023369A1 (es) 2002-09-04
IL144350A0 (en) 2002-05-23
BR0008321A (pt) 2002-01-29
PE20001468A1 (es) 2000-12-20
EP1153034A1 (en) 2001-11-14
DE60036785D1 (de) 2007-11-29
CA2362303A1 (en) 2000-08-24
CN1179972C (zh) 2004-12-15
CN1347420A (zh) 2002-05-01
ATE375996T1 (de) 2007-11-15

Similar Documents

Publication Publication Date Title
EP1326851B1 (en) Substituted dipeptides as growth hormone secretagogues
US5773441A (en) 2-acylaminopropanamides as growth hormone secretagogues
US6639076B1 (en) Growth hormone secretagogues
TW577879B (en) Novel compounds exhibiting growth hormone secretagogue activity, pharmaceutical composition containing the same and their uses
EP0898963A2 (en) Congestive heart failure treatment
JP2002539089A (ja) 成長ホルモン分泌促進薬
WO1997007117A1 (en) 2-acylaminopropanamines as growth hormone secretagogues
US6329342B1 (en) Treatment of congestive heart failure with growth hormone secretagogues
EP1497317B1 (en) Dipeptidic growth hormone secretagogues
US6828331B1 (en) Growth hormone secretagogues
US7125840B2 (en) Substituted dipeptides as growth hormone secretagogues
WO2000010565A1 (en) Growth hormone secretagogues
CA2340344A1 (en) Growth hormone secretagogues
MXPA01008309A (en) Growth hormone secretagogues
JP2002523368A (ja) 成長ホルモン分泌促進薬
US20060167268A1 (en) Growth hormone secretagogues
CZ2000596A3 (cs) Sekretagogy růstového hormonu, způsob jejich přípravy a farmaceutický prostředek s jejich obsahem
HK1058194B (en) Substituted dipeptides as growth hormone secretagogues

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070216

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070216

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070413

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100309

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20100803